Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence Perspective

• Main Authors: Ee Vien Low (Author), Hoon Shien Teh (Author), Nicholas Yee Liang Hing (Author), Suresh Kumar Chidambaram (Author), Mohan Dass Pathmanathan (Author), Wee Ric Kim (Author), Wei Jia Lee (Author), Zhi Wei Teh (Author), Maheshwara Rao Appannan (Author), Shahanizan Mohd Zin (Author), Faizah Muhamad Zin (Author), Samha Bashirah Mohamed Amin (Author), Mastura Ismail (Author), Azah Abdul Samad (Author), Kalaiarasu M. Peariasamy (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background and objectives Nirmatrelvir/ritonavir was administered orally to manage mild to moderate symptoms of COVID-19 in adult patients. The objectives of this study were to (i) evaluate the cost-effectiveness of prescribing nirmatrelvir/ritonavir within 5 days of a COVID-19 illness in o...